IP Verse

Luye Pharma competitive analysis

Latest publications and patents of Luye Pharma New

Explore the latest publications and patents granted to Luye Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Luye Pharma
EP3267981	May 5, 2021	Transdermal Therapeutic System With An Overtape Comprising Two Adhesive Layers	Granted And Under Opposition

Latest oppositions filed by Luye Pharma

Explore patent oppositions filed by Luye Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3658374	Device And Method For Producing Sealed Edge Bags	LTS LOHMANN THERAPIE SYSTEME	Jan 5, 2023
EP2515887	Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine	LTS LOHMANN THERAPIE SYSTEME	Mar 4, 2019
EP2790685	Transdermal Delivery System Comprising Buprenorphine	LTS LOHMANN THERAPIE SYSTEME	May 15, 2018

Latest patents of Luye Pharma opposed by its competitors

Explore Luye Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3267981	May 5, 2021	Transdermal Therapeutic System With An Overtape Comprising Two Adhesive Layers	1

Latest PTAB cases involving Luye Pharma

Discover the latest PTAB cases involving Luye Pharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 3, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Luye Pharma
IPR2016-01096	May 31, 2016	LUYE PHARMA GROUP	ALKERMES CONTROLLED THERAPEUTICS	Final Written Decision
IPR2016-01095	May 31, 2016	LUYE PHARMA GROUP	ALKERMES CONTROLLED THERAPEUTICS	Institution Denied

Peer Comparison New

IP litigation analysis comparing Luye Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
LUYE PHARMA SWITZERLAND	3	-	-	-	Highly Aggressive
LTS LOHMANN THERAPIE SYSTEME	6	10	-	-	Balanced
UCB BIOPHARMA	7	9	-	1	Balanced
UCB BIOPHARMA SPRL	-	5	-	-	Non-Active